Published date: 14 December 2016

Awarded contract - This means that the contract has been awarded to a supplier.


Closing: 16 May 2016

Contract summary

Industry

  • Medical practice services - 85121000

Location of contract

North West

Value of contract

£6,500,000

Procurement reference

L-15-03/2

Published date

14 December 2016

Closing date

16 May 2016

Contract start date

2 January 2017

Contract end date

1 January 2020

Contract type

Service contract

Procedure type

Restricted procedure

A two-stage procedure, where the first stage is used to select suppliers, who are then invited to bid in the second stage.

Contract is suitable for SMEs?

Yes

Contract is suitable for VCSEs?

Yes

Description

NHS Greater Preston Clinical Commissioning Group (CCG) and NHS Chorley and South Ribble CCG are seeking expressions of interest from suitably qualified and experienced organisations to deliver a high quality, comprehensive and efficient community based Tier 2 and Macular (Wet AMD and other similar conditions such as Diabetic Macular Oedema (DMO) and Retinal Vein Occlusion (RVO)) Ophthalmology
service.
The existing contract for the Tier 2 service is due for renewal and Wet AMD treatment is currently not provided locally. This opportunity has been used to review what is currently delivered and expand the service model that is provided for patients; including a Wet AMD treatment service locally and to include the utilisation of Anti VEGF treatments for DMO and RVO in the new service.
The CCG's wish to appoint a single provider for the provision of each element of the service
Lot 1: The Tier 2 Service; and
Lot 2: The Macular Service
to deliver the services across the combined CCG areas.
Timely local access to the service will enable GPs and Optometrists to refer patients quickly for expert opinion and diagnostic investigation without the need for the patient going into hospital. This will improve clinical outcomes for patients.
The service shall be delivered out of community locations in Preston, Chorley and South Ribble. This procurement will be split across two lots as below:
Lot 1: The Tier 2 element of the service will manage acute conditions including the following:
•Lids, Lashes, Tears;
•Red Eye and Red Eye Corneal Conditions;
•Vitreous;
•Raised Intraocular Pressure (IOP's);
•Blurred vision / field defects / retinal lesions / lens capsulotomy / minor surgery;
and
•Glaucoma
Lot 2: The Macular element of the service will provide patients with clinical assessment, diagnostic and treatment services for patients presenting with the following conditions:
•Wet AMD
•Diabetic Macular Oedema (DMO)
•Retinal Vein Occlusion (RVO)
The CCGs wish to include the use of Avastin in scenarios where it can be legally offered in the patients best interests. The provider will agree these scenarios with the commissioner.
NICE will publish a new AMD diagnosis and management guideline in August 2017. The CCGs understand that routine use of Avastin is covered in the guideline scope and the CCGs position will be reviewed at this point.

This is for a contract for 3 years with an option to extend for a further 2 years.
Anticipated contract start date is January 2017

More information

Previous notice about this procurement

Tier 2 and Macular Community Ophthalmology Service

  • Opportunity
  • Published 19 April 2016

Additional text

The overarching objectives of the service are to:
•Have Consultant Ophthalmologists at the core of the delivery responsible for ensuring that continuity and consistent quality of care is delivered by all members of the community Ophthalmology team.
•Ensure patients are seen and treated in the right place at the right time and by the most appropriate person
•Ensure that all patients have their initial treatment quickly and all subsequent treatments to plan
•Operate under a substantially lower than existing but sustainable tariff offering Value For Money (VFM)
•Offer new technology and treatments as they become available, for example Oraya Therapy, for all those who are eligible for it
•Ensure pro-active shared decision making (SDM) for patients and carers
•Ensure that Clinical practice/treatments are in line with the current
research/evidence-based care, ensure adherence to NICE Guidelines and/or any relevant locally developed guidance and evolve as the evidence evolves.
•Ensure that patients have a positive experience of care resulting in improvements in patient satisfaction.
•The service will ensure that all treatments are compliant with the Effective Use of Resources.
•A fully inclusive service will be available to all communities and, where necessary, make reasonable adjustment for individuals with cognitive, emotional and physical impairments.

Award information

Awarded date

11 November 2016

Contract start date

2 January 2017

Contract end date

1 January 2020

Total value of contract

£2,146,504

This contract was awarded to 2 suppliers.

Community Health and Eyecare

Address

34 Victoria Road, Fulwood, Preston, Lancashire PR2 2EE

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

Care UK Clinical Services Ltd

Address

Connaught House, 850 The Crescent, Colchester Business Park, Colchester, CO4 9QB

Reference

None

Supplier is SME?

No

Supplier is VCSE?

No

About the buyer

Contact name

Rachel Roocroft

Address

Jubilee House,
Lancashire Business Park,
Leyland,
PR26 6TR
England

Email

rachel.roocroft@nhs.net